From: Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Univariate Regression | Multivariate Regression | ||||
---|---|---|---|---|---|
Coefficient (95% CI) | P Value | Coefficient (95% CI) | P Value | ||
Treatment | |||||
Better Vision PPV | Reference | - | Reference | - | |
Worse Vision PPV | 1.45 (0.80 to 2.10) | < 0.001* | 1.42 (0.71 to 2.12) | < 0.001* | |
Injection | 0.60 (-0.15 to 1.35) | 0.117 | 0.52 (-0.21 to 1.25) | 0.164 | |
Sex | |||||
Female | Reference | - | - | - | |
Male | -0.61 (-1.35 to 0.13) | 0.106 | |||
Age | -0.02 (-0.05 to 0.01) | 0.088 | - | - | |
IVI Indication | |||||
AMD | Reference | ||||
DME | 0.23 (-0.72 to 1.19) | 0.632 | - | - | |
CRVO | 0.58 (-0.51 to 1.67) | 0.294 | |||
Other | 0.96 (-0.13 to 2.05) | 0.085 |